Top Markets
#1 DeFiChain DeFiChain +1,198.24%
#2 Superfortune Superfortune +102.53%
#3 The Black Bull The Black Bull +88.66%
#4 V.I.T.R.I.O.L. Network V.I.T.R.I.O.L. Network +82.96%
#5 Alien Worlds Alien Worlds +73.06%
#6 Metaplex Metaplex +69.70%
#7 TokenOS AI TokenOS AI +63.39%
#8 Nexus Nexus +53.26%
#9 Magma Finance Magma Finance +44.02%
#10 Hamster Kombat Hamster Kombat +32.59%
Coin of the day
DeFiChain DeFiChain
Settings
Language
ENGLISH
Currency
USD
Theme
Virbac SA Virbac SA

Virbac SA

VIRP
Rank in Stocks #3592
Virbac SA manufactures and sells a range of products and services for companion... Virbac SA manufactures and sells a range of products and services for companion and food-producing animals in France, Europe, Latin America, North America, the Asia Pacific, the Middle East, and Africa. The company offers a range of vaccines, dental hygiene, reproduction, dermatology, parasiticides, diagnostic, antibiotics, and aquaculture products; and veterinary medicines for anesthesia, geriatrics, behavior, and injectable micronutrients, as well as petfood and electronic identification. It serves veterinarians, farmers, and pet owners. Virbac SA was founded in 1968 and is headquartered in Carros, France.
Share Price
$393.80
Market Cap
$3.30B
Change (1 day)
0.15%
Change (1 year)
4.67%
Country
FR
Trade Virbac SA (VIRP)

Category

Healthcare
P/B ratio for Virbac SA (VIRP)
P/B ratio as of July 2026 TTM: 2.48
According to Virbac SA latest financial reports and stock price the company's current price-to-book ratio (TTM) is 2.48. At the end of 2023 the company had a P/B ratio of 3.32.
P/B ratio history for Virbac SA from 2002 to 2026
P/B ratio at the end of each year
Year P/B Ratio Change
2026 (TTM) 2.48 -2.17%
2024 2.54 -23.35%
2023 3.32 44.52%
2022 2.29 -53.61%
2021 4.95 52.98%
2020 3.23 -16.04%
2019 3.85 84.96%
2018 2.08 -12.22%
2017 2.37 -20.28%
2016 2.98 -29.60%
2015 4.23 24.08%
2014 3.41 -6.06%
2013 3.63 -0.51%
2012 3.64 12.45%
2011 3.24 -13.69%
2010 3.76 39.07%
2009 2.70 7.37%
2008 2.52 -22.55%
2007 3.25 29.93%
2006 2.50 9.61%
2005 2.28 28.69%
2004 1.77 -25.06%
2003 2.36 -2.29%
2002 2.42 0.00%
P/B ratio for similar companies or competitors
Company P/B Ratio P/B Ratio Difference Country
Eli Lilly Eli Lilly
Eli Lilly
LLY.US
 34.386 1,283.80%
US
Johnson & Johnson Johnson & Johnson
Johnson & Johnson
JNJ.US
 7.6493 207.83%
US
AbbVie Inc. AbbVie Inc.
AbbVie Inc.
ABBV.US
 16.2182 552.67%
US
Merck & Co., Inc. Merck & Co., Inc.
Merck & Co., Inc.
MRK.US
 6.919 178.44%
US
Novartis AG Novartis AG
Novartis AG
NVS.US
 7.7301 211.08%
CH